Titleist Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$309K Sell
2,070
-339
-14% -$47.6K 0.02% 368
2026
Q2
$304K Buy
2,409
+610
+34% +$80.4K 0.02% 347
2026
Q1
$251K Buy
1,799
+119
+7% +$16.7K 0.02% 358
2025
Q4
$206K Buy
+1,680
New +$204K 0.02% 369

Other funds holding GILD

Titleist Asset Management's GILD Position: Q3 2026 in Review

Titleist Asset Management reduced its Gilead Sciences (GILD) stake by 14% in Q3 2026, selling an estimated $47.6K and leaving 2,070 shares worth $309K. The position accounts for 0.02% of the portfolio, ranked #368.

Titleist Asset Management first reported a position in GILD in Q4 2025 and has held it in 4 quarters since. 119 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Titleist Asset Management held 2,070 shares of Gilead Sciences worth $309K as of Q3 2026.
  • Titleist Asset Management sold 339 Gilead Sciences shares in Q3 2026, an estimated $47.6K.
  • Gilead Sciences made up 0.02% of Titleist Asset Management's portfolio in Q3 2026, its #368 holding.
  • Titleist Asset Management first reported a position in Gilead Sciences in Q4 2025 and has held it in 4 quarters since.
  • 119 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Titleist Asset Management's 13F filing for Q3 2026, filed 8 Oct 2026.